Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2014-11-07, 14:16:52 | version 1.30.01
AccordingtotheIndo-AsianNewsService(IANS),apri- vateIndiannewsagency,AshikGavai,aGrade10pupil, wasadmittedtothehospitalon10Julycomplainingof painandwithanimmenseredswellingontherightside ofhisface. After a series of tests and examinations, the doctors suggestedthatacomplexcompositeodontoma,abe- nignodontogenictumour,wascausingthesymptoms. Duringthesubsequent7-hoursurgery,theyfoundthat theabnormalgrowthmeasuredabout3.5×2cm.The surgeons removed 232 teeth, with even more devel- oping, from the tumour.As the numerous small teeth were difficult to count,the doctors believe that in total theremayhavebeenmorethan350teeth. The doctors said that the boy had first noticed the swelling about a year and a half ago. However, high costs prevented him from seeking medical care and thetumourhadgrownunabated. IANS reported that the boy’s medical expenses were coveredbyRajivGandhiJeevandayeeArogyaYojana, a health scheme that ensures free care for low-in- come families, which was introduced by the Maha- rashtra government last year.Odontomas are usually asymptomatic and are often discovered during rou- tine dental X-rays. Several factors, including local trauma,infection,familyhistoryandgeneticmutation, may cause anomalous tissue development in odon- tomas. I 49implants3_2014 Audio visual communication of companies gain greater importance more and more since motion pic- turesdotriggeremotionsandtransmitcompactinfor- mation on short ways.The Bremer implant manufac- turer OT medical is using the communication device image film to present the company in its anniversary yearbymeansofamodernfilm. Sincefiveyearsnow,themottooftheBremenOTmed- icalGmbHis„InnovativeprecisionmadeinGermany“. Constant research and development, quality control without compromises and modern manufactur- ing processes do convince practitioners world- wide.Thereby,attributesascustomer-orientation, friendliness, good availability and short delivery timesareasamatterofcoursetotheimplantman- ufacturer. Founded in 2008, OT medical has es- tablisheditselfasasuccessfulnewcomerinden- talimplantologyandthusthecompanypresentit- selfwithanew,pleasantimagefilm. Oftentimes, films do say more than thousand words and are more personal and authentic than a brochure. However, what is needed to create a suc- cessful image film is a good idea.With the screenplay for its current image film, the company had the right idea.To capture as much authenticity as possible,the filmshootingwasdoneduringtheongoingdailybusi- ness and thus connects the company’s philosophy with professionalism and close customer proximity in asympatheticmanner.Aftertwoexhaustingbutgreat shooting days, all scenes are ready and the result is worthseeing… Right in time for its anniversary OT medical presents image film Indian teenager has Over 200 teeth extracted In a press release,Nobel Biocare stated:“In March 2014, Neodent USA launched its line of Drive CM dental implants in the US. In its complaint, Nobel Biocareallegesthattheseimplants,importedfrom Brazil,havestrikingsimilaritiestothedesignofthe NobelActive implants which Nobel Biocare com- merciallylaunchedin2008.Further,NobelBiocare asserts that Neodent USA has relied on Nobel Bio- care’s history of successful clinical data in mar- keting the Neodent product.” According to the Swiss-based company, both US patents asserted in the lawsuit relate to technol- ogy for aiding the surgical installation and suc- cessful integration of the implants in a variety of patient bone types. Nobel Biocare has asked the court for an injunction barring sales of Neodent's infringing dental implants, payment of money damages due to Nobel Biocare’s lost sales,and re- covery of its attorney fees for the lawsuit. In response to the allegations, Neodent USA said that it intends to defend itself vigorously against Nobel'sallegationsofpatentinfringementrelating to one of its implant ranges. The company stated that, prior to launching Drive CM, Neodent ob- tained in-depth evaluations to ensure that its de- signs respected all valid intellectual property rights. “The preliminary design of NobelActive was in- vented and developed by an Israeli team at Alpha- BioTec Ltd—not originally by Nobel Biocare, as many people believe.We did our homework before launching our range of implants in the US, espe- cially the Drive CM, and we are confident that we have not infringed any patents,” said Tony Susino, CEO of Neodent USA. Nobel Biocare sues Neodent USA for Patent infringement [PICTURE:©KORKUSUNG] [PICTURE: ©ALEXSKOPJE] Watch imagefilm